|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010042,
umls-concept:C0017262,
umls-concept:C0035015,
umls-concept:C0077503,
umls-concept:C0282554,
umls-concept:C0332237,
umls-concept:C0332307,
umls-concept:C1299003,
umls-concept:C1515895,
umls-concept:C1522168,
umls-concept:C1548437,
umls-concept:C1749467,
umls-concept:C1882923
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-12-15
|
|
pubmed:abstractText |
To determine the effect of topical soluble tumor necrosis factor receptor type I (sTNFR-I) on survival of murine orthotopic corneal transplants and on ocular chemokine gene expression after corneal transplantation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL4,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL5,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Inflammatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0003-9950
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
118
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1666-71
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11115261-Administration, Topical,
pubmed-meshheading:11115261-Animals,
pubmed-meshheading:11115261-Antigens, CD,
pubmed-meshheading:11115261-Chemokine CCL4,
pubmed-meshheading:11115261-Chemokine CCL5,
pubmed-meshheading:11115261-Cornea,
pubmed-meshheading:11115261-Corneal Transplantation,
pubmed-meshheading:11115261-Gene Expression,
pubmed-meshheading:11115261-Graft Rejection,
pubmed-meshheading:11115261-Graft Survival,
pubmed-meshheading:11115261-Macrophage Inflammatory Proteins,
pubmed-meshheading:11115261-Male,
pubmed-meshheading:11115261-Mice,
pubmed-meshheading:11115261-Mice, Inbred BALB C,
pubmed-meshheading:11115261-Nuclease Protection Assays,
pubmed-meshheading:11115261-Ophthalmic Solutions,
pubmed-meshheading:11115261-RNA, Messenger,
pubmed-meshheading:11115261-Random Allocation,
pubmed-meshheading:11115261-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11115261-Receptors, Tumor Necrosis Factor, Type I,
pubmed-meshheading:11115261-Solubility,
pubmed-meshheading:11115261-Transplantation, Homologous,
pubmed-meshheading:11115261-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants.
|
|
pubmed:affiliation |
Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
